Technology

Artificial Intelligence Big Data Cloud Computing Cyber Security Data Management Electronics Enterprise & Network Technology Financial Technology Hardware Mobile & Wireless Nanotechnology Semiconductor Software Telecommunications
News Release Digital Asset Direct

Upcoming ETF Verdict Spurs Crypto Buy Pressure: Bitcoin, Ethereum, and Raboo Set for Further Gains

Total Media

As anticipation mounts with the upcoming ETF verdict, the crypto market sees a surge in buy pressure. Bitcoin and Ethereum, already household names, are joined by the emerging contender Raboo, currently in the limelight with its presale. Priced at a mere $0.003, Raboo is not just any token—it's forecasted to skyrocket by 100x in 2024. With analysts buzzing over the Bitcoin price prediction and the potential approval of an Ethereum ETF, the stage is set for monumental gains. Raboo, in particular, stands at a pivotal 233% growth expectation during its presale, heralding an explosive entry into the crypto scene. Bitcoin's wild March: Highs, lows, and the unstoppable rise to the top Bitcoin's dance on the financial stage has been nothing short of a thriller this March. Hitting an all-time high, Bitcoin swiftly took a 10% tumble, causing a frenzy of over $1 billion in crypto liquidations. Yet, amidst this rollercoaster, the crypto titan stands resilient, buoyed by news of BlackRock's Bitcoin ETF potentially eclipsing Grayscale's holdings, setting the stage for a seismic shift in institutional holdings. With Bitcoin's halving on the horizon, the buzz around its future Bitcoin’s price performance intensifies, keeping enthusiasts on the edge of their seats. This unpredictability, combined with expert Bitcoin price predictions hinting towards $100,000, teases a future where Bitcoin's influence only grows stronger. Ethereum: Skyrocketing prices and groundbreaking upgrades unleashed Keeping up with the Bitcoin price prediction is Ethereum which has seen its recent trajectory sail past $3,500, invigorated by the upcoming potential approval of the Ethereum ETFs. The anticipation around Ethereum and its evolving ecosystem, including pivotal upgrades and market enthusiasm, positions Ethereum for an exhilarating leap forward. Ethereum, standing at the precipice of innovation, continues to captivate investors and developers alike. Raboo rises: A meme revolution unleashed, setting the digital world ablaze Raboo is set to redefine the meme landscape by marrying social-fi and AI, creating a dynamic arena for meme aficionados. This platform transforms users into vital contributors within a flourishing ecosystem of NFTs and AI-enhanced memes, fostering an unprecedented level of creative engagement. Raboo's narrative, a digital realm in 3024 overrun by mundane memes, sets the stage for its rise as the savior of digital creativity, wielding an AI capable of evolving and curating high-quality content. The RABT token, beyond mere trading, acts as the backbone of this community, incentivizing participation through challenges and exclusive giveaways. The anticipation around its presale, priced attractively at $0.003, hints at a 366% growth potential before launch, aiming for a spectacular 100x increase on debut. Raboo's vision extends to eclipsing giants like Shiba Inu and Dogecoin, propelled by a unique tokenomics strategy, including a deliberate crypto burn to enhance value. With features like Rabooscan and exclusive NFTs for early supporters, Raboo is a unique long-term investment opportunity for crypto enthusiasts. Conclusion As the crypto market heats up with the impending ETF decisions for Ethereum, the spotlight intensifies on Raboo. With its presale quickly selling out, Raboo represents a fleeting, golden opportunity for early investors. This surge of interest underscores the urgency and potential of Raboo, alongside stalwarts like Bitcoin and Ethereum, as they head toward unprecedented growth. You can participate in the Raboo presale here. Contact Details Total Media Solutions media@Totalsolutionspr.io

April 03, 2024 03:25 PM Eastern Daylight Time

Image

AdvicePay 2024 Fee-for-Service Industry Trend Report Shows Marked Increase in Fees Advisors Charge for Fee-Based Financial Planning

AdvicePay

In 2023, financial advisors saw an increase in the amount of fees they were able to charge clients who engaged them in fee-for-service financial planning, according to the 2024 Fee-for-Service Industry Trend Report from AdvicePay, the industry-leading platform for processing payments and overseeing compliance of fee-for-service financial planning. Last year, monthly recurring subscriptions for planning fees rose to $265 per client, up 6% from 2022. Quarterly recurring subscriptions averaged $968 per client, up 1.6%. One-time payments rose 6.7% to $1,578, according to AdvicePay’s proprietary data. Financial advisors continue to prefer subscription models. According to the report, 83% of all invoices sent through AdvicePay were for subscriptions, and 74% of all invoices were monthly recurring. Half of all advisors bill their clients monthly, while 22% bill quarterly. Advisors reported that clients remain receptive to fee-for-service financial planning because it aligns with their accustomed payment models for other subscription services, such as Netflix. This approach enables them to conveniently compensate their advisors using their cash flow while adding an extra layer of transparency. “We continue to find that there are more consumers looking for financial planning than there are financial planners to provide that fee-for-service offering,” said Alan Moore, Co-Founder and Chief Executive Officer of AdvicePay. “What’s more, the retention rates are extremely high in an ongoing financial planning relationship, and the latest data show that the economics continue to be very favorable.” According to research issued by Cerulli Associates and the Securities Industry and Financial Markets Association (SIFMA), there has been a notable shift, with 63% of investors expressing a willingness to pay for advice, up from the 38% reported in 2009. The research also highlights a heightened demand for personalized, comprehensive advice with a focus on formal financial plans rising from 38% to 54% over the past 14 years. Most advisors surveyed offer additional services outside of fee-based planning. According to the data, 88.4% offer investment management, while 82.1% provide tax planning. Increasingly, more advisors are offering guidance on held-away accounts like 401(k)s, with 63.1% of financial advisors reporting this is a service they provide. The 2024 AdvicePay Fee-for-Service Industry Trend Report draws upon insights gleaned from over 380,000 fee-for-service financial planning transactions conducted through the company’s platform. To receive a copy of the full report, please visit https://info.advicepay.com/trends. About AdvicePay Established by well-known financial advisors Michael Kitces and Alan Moore, AdvicePay is the industry-leading billing and payment workflow solution created specifically for fee-for-service financial planning. Financial services firms and their advisors benefit from efficient workflows designed exclusively to support their fee-for-service financial planning revenue, including up-to-date compliance and data security management, all in one unified platform. Contact Details Shannon Beck +1 406-412-2047 media@advicepay.com Company Website https://advicepay.com/

April 03, 2024 01:22 PM Eastern Daylight Time

MedCognetics Secures Groundbreaking Patent for Inclusive, Unbiased Medical Imaging AI Technology in Mammography

MedCognetics

In a significant stride towards equitable healthcare technology, MedCognetics, Inc., a company focusing on medical imaging AI, today announced it has been awarded patent number 11,948,297 by the United States Patent and Trademark Office (USPTO). The patent covers architectural strategies and methodologies for achieving unbiased AI in breast imaging. This innovation is backed by MedCognetics’ peer-reviewed publications in industry conferences such as the Radiological Society North America (RSNA) 2023, the European Society of Radiology (ESR) 2024, and a grant from the National Institutes of Health (NIH). This breakthrough is set to redefine the development of AI in the medical field ensuring MedCognetics’ algorithms maintain high performance across different patient demographics, thereby guaranteeing consistent, fair, superior patient outcomes. "This patent is a reflection of our team's focused pursuit of innovation and commitment to inclusivity,” said Ron Nag, CEO of MedCognetics, Inc. “Our technology is not just about improving patient outcomes through earlier and more accurate diagnoses; the focus is on fostering equality in technological development and ensuring universal access to advancements in healthcare systems worldwide. We remain dedicated to progressing in the field of unbiased medical imaging technology.” MedCognetics is actively engaged in partnerships with leading healthcare institutions and research organizations to bring its patented AI technology into clinical practice, aiming for widespread patient benefit from these advancements at the earliest. Full details of the allowance are listed in the Issue Notification Certificate issued by the USPTO. For further information about MedCognetics and its pioneering medical imaging AI technology, please visit www.medcognetics.com. About MedCognetics, Inc. MedCognetics provides an advanced AI software platform that integrates into radiology workflow. In addition, the AI algorithm is trained on a diverse global patient dataset to mitigate data biasing. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating a more predictable medical outcome and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com. Contact Details ANW Networks Alicia Nieva-Woodgate +1 415-515-0866 alicia@anwnetworks.com Company Website https://www.medcognetics.com

April 03, 2024 11:30 AM Eastern Daylight Time

Nextech3D.ai protects intellectual property with a patent for generating 3D models from 2D images

Nextech3D.AI

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce a significant milestone for the company as the U.S. Patent and Trademark Office (USPTO) officially issued a patent for their technology to generate three-dimensional models from two-dimensional images. Gappelberg emphasized the importance of this patent in the realm of artificial intelligence (AI) and 2D to 3D model generation, describing it as a pivotal patent for the 3D modeling industry. He highlighted that this patent adds substantial value to Nextech3D.ai and positions the company as one of the technology leaders in the field of converting 2D photos to 3D models using AI. The issuance of this patent provides Nextech3D.ai with a competitive advantage, setting them apart from other companies involved in 3D model generation. Gappelberg expressed confidence that this patent, along with a second AI patent issuance and seven additional patents filed, strengthens the company's position and builds a moat around their 3D model-making business for e-commerce. With a focus on both industry expertise and intellectual property, including GPT AI-powered 3D model generation, Nextech3D.ai aims to increase shareholder value by investing in 3D-AI GPT patents and solutions. Gappelberg emphasized that this second AI patent approval reinforces and validates the company's commitment to innovation and generating substantial revenue through 3D modeling. Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

April 03, 2024 11:20 AM Eastern Daylight Time

Video

PathAI Announces Research Presentations at the 2024 AACR Annual Meeting

PathAI

PathAI, Inc., a leading AI-powered precision pathology company, today announced it will present research from its portfolio of oncology products at the AACR Annual Meeting on April 7-10, 2024, in San Diego, CA. The research demonstrates how machine learning models developed to characterize the tumor microenvironment (TME) from routine hematoxylin and eosin (H&E)-stained whole slide images (WSIs) can be used to advance biomarker development and precision medicine strategies. The presentations include new research leveraging PathAI’s pan-tumor foundation models and its commercially available product, PathExplore 1, to identify key histologic features associated with molecular signatures and patient response to therapy. Highlights: Researchers deployed PathExplore on HNSCC and NSCLC samples to characterize the cell and tissue composition of the tumor microenvironment, as well as compute immune phenotypes directly from H&E WSI. (Poster #905 ) Researchers from Incendia Therapeutics developed a continuous scoring method for Discoidin Domain Receptor 1 (DDR1), which revealed widespread immune exclusion in tumors based on the spatial distribution of lymphocytes, CD8+ T cells, and CD45+ immune cells from H&E and mIF images. DDR1 is highly expressed in epithelial cancers and has been implicated in tumor growth, invasion, and lack of response to therapy. The immune exclusion score correlates with DDR1 mRNA and protein expression. The study provides additional insight into the role of DDR1 in human cancers and may be useful in selecting indications and stratifying patients for DDR1-targeted therapies. (Poster #2916 ) Using unsupervised learning driven by PathExplore’s features and a novel collagen fiber detection imaging technology, researchers discovered three distinct phenotypes of cancer associated stroma (CAS) that had distinct patterns of association with survival and gene expression signatures. Two of them were enriched in collagen fiber density as well as in density of fibroblasts, while the third phenotype had the highest density of immune cells, providing a categorization of different types of CAS-tumor interaction that may be useful for patient stratification. (Poster #4912 ) Using AI-powered models from PathAI, Foundation Medicine researchers investigated digital pathology TME features of immunotherapy outcomes among NSCLC patients within a real-world dataset from the Flatiron Health-Foundation Medicine Clinico-Genomic Database. These results indicate that the composition of the TME assessed via digital pathology may have utility in identifying NSCLC patients who will respond to first-line immune checkpoint inhibitors beyond the established immunotherapy biomarkers. (Poster #4969 ) In collaboration with EMD Serono, AI-powered TME models from PathAI were used to analyze H&E WSI of NSCLC from a randomized Phase 3 trial directly comparing two immunotherapies. Researchers compared cell abundance features with gene expression data from the same samples and found that immune and stromal cell abundance features were associated with expression of genes in relevant cellular pathways, confirming the biological relevance of our cellular features. In analyzing the features alongside the clinical data from the retrospective study, researchers identified candidate prognostic immunotherapy biomarkers. (Poster #6179 ) Researchers from Incendia Therapeutics illustrated that morphologic features derived from H&E images using PathExplore can be effective predictors of CD8-defined immune exclusion, providing an option for patient stratification by immune phenotype using widely available H&E images. The features and direction of association align with prior knowledge of the mechanism or manifestations of immune exclusion or infiltration in the TME, including the relative density of lymphocytes in tumor and stroma. (Poster #7392 ) PathAI’s pan-tumor foundation models were used to identify tissue regions and cell types on H&E WSI to quantify tumor purity across multiple tumor types. Model-derived tumor purity estimates were compared to three orthogonal molecular methods of purity and found to correlate across disease indications. These results provide evidence of how AI can improve the efficiency of molecular testing and enhance precision diagnostic strategies. (Poster #7402 ) Follow PathAI on LinkedIn and X for more updates from #AACR24 and visit us in person at booth #1549. 1 PathExplore is For Research Use Only. Not for use in diagnostic procedures. About PathAI PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and laboratory use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of pathology samples to improve efficiency and accuracy of pathology interpretation, as well as to better gauge therapeutic efficacy and accelerate drug development for complex diseases. PathAI, which is headquartered in Boston, MA, and operates a CAP/CLIA-certified laboratory in Memphis, TN, is proud to have a team of 600+ innovative thinkers from around the globe. For more information, please visit www.pathai.com. Contact Details SVM Public Relations and Marketing Communications Maggie Naples +1 401-490-9700 pathai@svmpr.com Company Website https://www.pathai.com/

April 03, 2024 10:00 AM Eastern Daylight Time

Analyst Crypto Jebb Urges To Buy Ethereum Right Now! Cardano Left in the Dust As KangaMoon Bull Run Continues!

Kangamoon

Renowned analyst Crypto Jebb has been talking about Ethereum (ETH) a lot lately and people are starting to listen. Meanwhile, Cardano (ADA) has been outshined by many altcoins like KangaMoon (KANG), which is on a massive bull run. This Stage 5 presale star has already provided early buyers with 291% ROI, causing many experts to hint at a $0.5 price in 2024. Crypto Jebb: Ethereum Price Will Moonshot Recently, Ethereum (ETH) has been on an uptrend. Over the past 30 days, the Ethereum price soared from $3,409 to $3,557. During that time, its market cap increased from $410B to $427B. According to crypto analyst Crypto Jebb, this bullish trend will continue for the Ethereum crypto. He forecasts a potential 10x on ETH within the next ten years. This altcoin's technical analysis also shows a bullish future. For instance, Ethereum is now trading above its 100— and 200-day EMAs. Additionally, 25 technical indicators are showing green for ETH. As a result, experts have made a bullish Ethereum price prediction. They foresee this altcoin's price hitting $4,489 within Q2 of 2024. Cardano (ADA): Trading in the Red On the other hand, Cardano (ADA) has been trading in the red. According to CoinMarketCap data, the Cardano price sank from $0.73 to $0.63 over the past month. In that period, its market cap also fell from $26B to $22.46B. However, the technical analysis for this altcoin paints a different picture. Notably, the Cardano coin is trading above its 100 and 200-day EMAs. Additionally, this altcoin now has over 20 technical indicators showing bullish signs. Due to all these reasons, market analysts have made a bullish Cardano price prediction - a rise to $0.86 within Q2 of 2024. KangaMoon (KANG): Becoming One of the Altcoins To Watch While Ethereum and Cardano experience ups and downs, KangaMoon (KANG) has surfaced as an unexpected contender. This presale star has already soared by 291%, with 20,000 registered community members. Moreover, KangaMoon has raised over $3.9M and projects reaching $5M before April 2024 ends. Essentially, KangaMoon will develop a Play-to-Earn (P2E) game in which KANG will serve as the main in-game currency. With KANG, you can buy character upgrades or in-game items. Additionally, KANG holders gain exclusive access to challenges for extra tokens or in-game items. Another impressive part of KangaMoon is its dedication to cultivating an active community. As an example, users can earn free KANG tokens by being engaged members before the official launch. This has caused a significant surge in social media interaction as traders eagerly like, share and retweet KangaMoon's content. All these factors have helped KangaMoon obtain over 5,800 holders. Currently, one KANG token costs just $0.0196 - a 291% rise from its starting price of $0.005. Experts remain bullish as they forecast a rise to $0.5 once a Tier-1 CEX lists this altcoin in Q2 of 2024. This price prediction seems plausible with ties to the P2E gaming market, which will reach $885M by 2028. Will KangaMoon Rise Faster than Ethereum and Cardano? With its low $14M market cap, KangaMoon could outshine Ethereum and Cardano. This means it needs fewer new funds so the price can skyrocket faster. If you want to buy one of the top altcoins, sign up for its presale using the links below and get a 10% bonus. Discover the Exciting Opportunities of the KangaMoon (KANG) Presale Today! Website: https://Kangamoon.com/ Join Our Telegram Community: https://t.me/Kangamoonofficial Integrating GameFi and Play To EarnEmbark on your quest for glory. Assemble your champions, engage in epic battles or bet on your favorite fighters to earn $KANG tokens and exclusive rewards. Gain control of rare NFTs, unlock exclusive content and build alliances with fellow gamers as you ascend the ranks and leaderboards. Disclaimer: The following disclaimer is important to read and understand before engaging with Kangamoon, a play-to-earn meme coin. By accessing or participating in any activities related to Kangamoon, you acknowledge and accept the terms outlined below: 1 No Financial Advice: This whitepaper and any associated content do not constitute financial advice, investment recommendations, or solicitation to purchase Kangamoon tokens. The information provided is for informational purposes only. It is your responsibility to conduct thorough research and seek professional advice before making any financial decisions. 2 Volatility and Risks: Cryptocurrencies, including Kangamoon, are volatile and subject to significant price fluctuations. Investing in or holding Kangamoon tokens involves substantial risks, including the possibility of total loss. Past performance is not indicative of future results. 3 Regulatory Compliance: The regulatory environment surrounding cryptocurrencies is evolving and varies across jurisdictions. It is your responsibility to ensure compliance with applicable laws and regulations in your country or region before engaging with Kangamoon. 4 Uncertain Market: The market for meme coins and play-to-earn platforms is highly speculative and subject to rapid changes. There is no guarantee of market demand, liquidity, or utility for Kangamoon tokens. Token values may fluctuate drastically and may not reflect the intrinsic value of the project. By continuing to engage with Kangamoon, you acknowledge and accept the risks and limitations outlined in this disclaimer. You should only participate if you fully understand and are willing to assume these risks. Contact Details Kangamoon marketing@kangamoon.com Company Website https://kangamoon.com/

April 03, 2024 09:00 AM Central Daylight Time

Image

What's next for Bitcoin? ETC Group CEO breaks down ETFs & market trends

HANetf Holdings Limited

ETC Group CEO Tim Bevan discusses the recent volatility in Bitcoin prices, attributing it to macroeconomic factors and specific market events. In an interview with Proactive's Stephen Gunnion, Bevan noted the unexpected strength in the US economy indicated by recent jobs data, which has led to revised expectations for interest rate cuts, impacting risk assets like Bitcoin. The movement of $2 billion worth of confiscated Bitcoin related to the Silk Road case onto a Coinbase account by the US Department of Justice (DOJ) has also contributed to the market's instability. Despite these short-term drivers, Bevan views the fluctuations as part of Bitcoin's usual trading range. Regarding the likelihood of an Ethereum ETF in the US, Bevan indicated a negative shift, citing the SEC's increased efforts to classify Ethereum as a security. This classification, driven by interactions with the Ethereum Foundation and the transition to proof of stake, marks a significant regulatory change and dampens the immediate prospects for an Ethereum ETF. Nonetheless, Bevan remains hopeful for developments later in the year. Bevan also commented on the London Stock Exchange's (LSE) decision to launch a segment for crypto ETPs, viewing it as a positive step for market legitimization. However, he critiqued the exclusion of retail investors from this segment, suggesting it could limit market liquidity and appeal. Lastly, Bevan discussed the upcoming Bitcoin halving event, a reduction in the reward for mining Bitcoin, anticipated around 20 April. He stressed that while the halving itself may not instantly affect prices, its long-term impact on supply could be significant. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 03, 2024 09:42 AM Eastern Daylight Time

Video

Ethernity Networks forecasts substantial growth with new OEM engagements

Ethernity Networks Ltd

Ethernity Networks Ltd (AIM:ENET, OTCQB:ENETF) vice president of marketing and business development Ilan Tevet shares the company's promising business outlook for 2024 and beyond based on current customer engagements. Tevet told Proactive's Stephen Gunnion Ethernity is in advanced discussions with two Original Equipment Manufacturer (OEM) customers, testing the Universal Edge Platform 2025 (UEP2025) platform for launching solutions targeting distinct markets: a 25 Gigabit Ethernet Carrier Ethernet switch for business services and a similar switch with bonding capability for the wireless backhaul market. These engagements are anticipated to significantly enhance Ethernity's revenue in 2024, showcasing a remarkable growth trajectory. Tevet said the increasing demand for high-capacity Carrier Ethernet Access switches is driven by the widespread adoption of cloud services and the surge in video conferencing and AI applications, which intensify bandwidth usage. Furthermore, the wireless backhaul market is expanding to accommodate the escalating data consumption by smartphones, with a forecasted CAGR of 37% through 2027. Ethernity addresses the challenges of environmental sensitivity in wireless link capacity through its patented bonding technology, enabling optimal service delivery by aggregating multiple wireless links. He said Ethernity also offers versatile business models to meet OEM customer needs, including system sales for rapid revenue generation, a licensing model for custom integration, and the development of an Application-Specific Integrated Circuit (ASIC) for cost reduction and performance enhancement. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 03, 2024 09:38 AM Eastern Daylight Time

Video

AI platform SiftHub raises $5.5m as it rescues sales & presales teams from repetitive tasks

SiftHub

Information overload from ad campaigns, email marketing, and a company’s website means that buyers are equipped with more than a basic understanding of a product or service well before a sales meeting. This means sellers need deeper product knowledge and easy access to proprietary company information to win new customers. However, the current sales tech stack does not support this foundational shift in the role of sales and presales teams. AI platform for sales SiftHub has today raised $5.5 million in seed funding to help sales and presales teams discover knowledge and generate responses to customer needs immediately. The funding round was led by Matrix Partners India and Blume Ventures with participation from Neon Fund and executive operators and founders from Superhuman, Cloudflare, DevRev, RazorPay, and SuperOps. SiftHub’s AI platform is changing how sales and presales teams discover up-to-date information and generate accurate responses grounded in company knowledge. No more “I’ll get back to you”s that could lead to a lost opportunity. One-click integrations with workplace apps such as CRM, content repository, knowledgebase, and more allow SiftHub to bring all enterprise knowledge into a single, accessible hub. Its unified semantic search capabilities make it easy to find the right information at the right time without toggling between screens. “After speaking to 200+ leaders, it dawned on me that it’s completely unreasonable to expect sales and presales professionals to memorize all the ins and outs of the product in order to be able to respond to clients with complex technical details. Trying to find up-to-date accurate information when it is scattered across Slack, Gmail, Drive, HubSpot, Confluence, and more is incredibly difficult. The fact that sales spends only 30% of their time selling cries for a change - and that’s where our platform comes in.” said Manisha Raisinghani, Founder of SiftHub. SiftHub is uniquely positioned to deliver secure, private, access-controlled answers that trace back to the source. Using RAG technology and fine-tuned LLMs with industry-specific knowledge training, SiftHub allows companies to generate personalized responses with zero hallucinations. This guarantees increased transparency and reduced risk and inspires absolute trust to use AI for all their needs. Now, sales teams can finally focus on what they do best - selling! SiftHub simplifies the usually time-consuming back-and-forth between sales and various other teams as a deal progresses. With its easy-to-use project management and seamless workflow automation capabilities, the platform helps streamline collaboration between teams as they complete infosec questionnaires, vendor assessment forms, RFPs, and RFIs. SiftHub was founded in July 2023 by Manisha Rasinghani, a second-time founder. Before SiftHub, she co-founded LogiNext as CTO and raised over $50m from Tiger Global and others. “GenAI is not just a technology, it’s a revolution in productivity. It unlocks the ability to solve a legacy problem in a modern way improving efficiency by 80%,” said Manisha Raisinghani, “By integrating GenAI with advanced workflow automation and collaborative capabilities, we’re providing an end-to-end solution for our users. From the moment the first information request is received to the closure of each sale with satisfactory responses, SiftHub will remain a trusted partner for sales organizations.” Pranay Desai, Managing Director at Matrix Partners India commented: "Buyers have become smarter and engage sales later in the buying journey, with more advanced questions. As a result, the expectation from sales teams has changed - they need to know advanced product, technical, and legal information to get the win. Sales and presales teams lack the necessary tooling to handle this new selling environment. We are excited by SiftHub's vision to use AI to manage product knowledge so that sales can focus on relationships." Sanjay Nath, Partner at Blume Ventures, said, “SiftHub is Manisha’s second venture in the SaaS space. Armed with over a decade of entrepreneurial experience and an impressive track record, Manisha and her team are building a game-changing AI platform to transform the entire sales and presales process. We are excited to back the SiftHub team and be a part of their ambitious journey.” About SiftHub Founded by Manisha Raisinghani, SiftHub is an AI platform that acts as a central hub to collate and sift through all your content scattered across multiple repositories and tools. Through accelerated knowledge discovery and automated response creation, SiftHub empowers your sales and pre-sales teams to improve win rates and close deals faster. Headquartered in the United States, SiftHub also has an R&D office in Mumbai, India. About Matrix Partners India Founded in 2006, Matrix Partners India invests in companies targeting the consumer and enterprise market at the seed, early and early growth stages. The firm has invested in several enterprise technology companies such as MoEngage (Customer engagement platform), Toddle (Teaching & learning platform), SuperOps.ai (AI-powered PSA-RMM platform), Rocketlane (Customer onboarding platform), Murf AI (Synthetic speech technology), 100ms (Live video infrastructure) and Atomicwork (Employee success solution) amongst others. Other marquee investments include Dailyhunt (Local language platform), Five Star Business Finance (SME lending), OfBusiness (B2B commerce, fintech), Ola (Mobility), Ola Electric (Electric vehicles), OneCard (Mobile-first credit card), Oxyzo (Tech-enabled smart financing), Razorpay (Payments), Country Delight (D2C dairy & fresh foods brand), GoKwik (E-commerce enablement platform), Jupiter (Neobank), and Mosaic Wellness (Health & wellness), among others. Matrix Partners India has advisory offices in Bangalore, Delhi and Mumbai. Further information is available at www.matrixpartners.in. To know more about our investment philosophy & ideologies, check out the #MatrixMoments podcast series. About Blume Ventures Blume Ventures is an early-stage India-focused venture fund that backs startups with both funding as well as active mentoring. Blume typically invests in Seed and pre-Series A rounds in tech-led startups led by founders obsessed with solving hard problems for the Indian market and from India for the world. Blume presently invests out of Fund IV, a $300M vehicle supported by leading institutional LPs and family offices. With the close of Fund IV, Blume now has an AUM (Assets Under Management) of over $600m, managed by an investment team based across Bengaluru, Mumbai, Delhi, and San Francisco. Some of the leading startups we have backed included Purplle, Unacademy, Spinny, slice, Carbon Clean, and GreyOrange. Contact Details SiftHub Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.sifthub.io/

April 03, 2024 09:00 AM Eastern Daylight Time

Image

1 ... 84 85 86 87 88 ... 647